ID: ALA3675788

Max Phase: Preclinical

Molecular Formula: C13H9N3O2

Molecular Weight: 239.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=COc1ccc2nc(-c3ccccn3)[nH]c2c1

Standard InChI:  InChI=1S/C13H9N3O2/c17-8-18-9-4-5-10-12(7-9)16-13(15-10)11-3-1-2-6-14-11/h1-8H,(H,15,16)

Standard InChI Key:  ZBUGDSFQUUHGDU-UHFFFAOYSA-N

Associated Targets(Human)

Core-binding factor subunit beta 36 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 239.23Molecular Weight (Monoisotopic): 239.0695AlogP: 2.16#Rotatable Bonds: 3
Polar Surface Area: 67.87Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.18CX Basic pKa: 2.36CX LogP: 2.01CX LogD: 2.01
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.71Np Likeness Score: -0.68

References

1.  (2014)  Inhibitors of inv(16) leukemia, 

Source

Source(1):